NOVAVAX INC (NVAX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 250M 500M 750M Q3 '21: 178.8M Q4 '21: 222.2M Q1 '22: 704M Q2 '22: 185.9M Q3 '22: 734.6M Q4 '22: 357.4M Q1 '23: 81M Q2 '23: 424.4M Q3 '23: 187M Q4 '23: 291.3M Q1 '24: 93.9M Q2 '24: 415.5M Q3 '24: 84.5M Q4 '24: 88.3M Q1 '25: 666.7M Q2 '25: 239.2M Q3 '25: 70.4M Q4 '25: 147.1M Q1 '26: 139.5M Q2 '26: 56.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-250M 0 250M 500M 750M Q3 '21: 178.8M Q4 '21: 222.2M Q1 '22: 688.8M Q2 '22: -85.2M Q3 '22: 300M Q4 '22: 175.6M Q1 '23: 46.9M Q2 '23: 368.6M Q3 '23: 88.1M Q4 '23: 136.4M Q1 '24: 34.6M Q2 '24: 369.2M Q3 '24: 23.9M Q4 '24: 51.6M Q1 '25: 652.5M Q2 '25: 223.9M Q3 '25: 48.9M Q4 '25: 125M Q1 '26: 108.8M Q2 '26: 42.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-900M -600M -300M 0 300M 600M 900M Q3 '21: -307.1M Q4 '21: -825M Q1 '22: 209.3M Q2 '22: -483M Q3 '22: -127.2M Q4 '22: -243.9M Q1 '23: -312.8M Q2 '23: 55.5M Q3 '23: -125.6M Q4 '23: -183.6M Q1 '24: -144.8M Q2 '24: 161M Q3 '24: -134M Q4 '24: -131.1M Q1 '25: 515.5M Q2 '25: 101.1M Q3 '25: -178M Q4 '25: 14.2M Q1 '26: -15.4M Q2 '26: -54.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-900M -600M -300M 0 300M 600M 900M Q3 '21: -322.4M Q4 '21: -846.3M Q1 '22: 203.4M Q2 '22: -510.5M Q3 '22: -168.6M Q4 '22: -182.2M Q1 '23: -293.9M Q2 '23: 58M Q3 '23: -130.8M Q4 '23: -178.4M Q1 '24: -147.6M Q2 '24: 162.4M Q3 '24: -121.3M Q4 '24: -81M Q1 '25: 518.6M Q2 '25: 106.5M Q3 '25: -202.4M Q4 '25: 17.5M Q1 '26: -9.5M Q2 '26: -53.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 150M 300M 450M Q3 '21: 0 Q4 '21: 0 Q1 '22: 15.2M Q2 '22: 271.1M Q3 '22: 434.6M Q4 '22: 181.8M Q1 '23: 34.1M Q2 '23: 55.8M Q3 '23: 98.9M Q4 '23: 155M Q1 '24: 59.2M Q2 '24: 46.2M Q3 '24: 60.6M Q4 '24: 36.7M Q1 '25: 14.1M Q2 '25: 15.3M Q3 '25: 21.5M Q4 '25: 22.1M Q1 '26: 30.7M Q2 '26: 14.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-450M -300M -150M 0 150M 300M 450M Q3 '21: -142.1M Q4 '21: -342.4M Q1 '22: -88.5M Q2 '22: -170.9M Q3 '22: -38.7M Q4 '22: -117.8M Q1 '23: -325.6M Q2 '23: -171.9M Q3 '23: -39.7M Q4 '23: -176.8M Q1 '24: -83.6M Q2 '24: 314.3M Q3 '24: -144.8M Q4 '24: -173.2M Q1 '25: -185.5M Q2 '25: -127.5M Q3 '25: 107.8M Q4 '25: -39.5M Q1 '26: -32.4M Q2 '26: -72.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-500M -250M 0 250M 500M 750M Q2 '17: -13.6M Q3 '17: -45.4M Q4 '17: -44M Q1 '18: -66.2M Q2 '18: -40.3M Q3 '18: -33.9M Q4 '18: -45.8M Q1 '19: -51.4M Q2 '19: -30.5M Q3 '19: -32.6M Q4 '19: -24M Q1 '20: -23.2M Q2 '20: 111.9M Q3 '20: -15.2M Q1 '21: 649.3M Q2 '21: 129.3M Q3 '21: -154.3M Q4 '21: -358.8M Q1 '22: -105.3M Q2 '22: -195.5M Q3 '17 Q2 '18 Q1 '19 Q4 '19 Q3 '20 Q3 '21 Q2 '22

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q2 '20: 58.6M Q3 '20: 61.6M Q1 '21: 73M Q2 '21: 74.1M Q3 '21: 74.7M Q1 '22: 80.7M Q2 '22: 78.1M Q3 '22: 78.3M Q1 '23: 86.2M Q2 '23: 104.1M Q3 '23: 103.4M Q1 '24: 139.9M Q2 '24: 165.9M Q3 '24: 160M Q1 '25: 177.6M Q2 '25: 177.2M Q3 '25: 162.4M Q1 '26: 163.3M Q2 '26: 164.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-24.00 -16.00 -8.00 0.00 8.00 16.00 24.00 Q3 '21: -14.99 Q4 '21: -23.42 Q1 '22: -17.81 Q2 '22: -19.59 Q3 '22: -17.43 Q4 '22: -8.41 Q1 '23: -14.38 Q2 '23: -7.27 Q3 '23: -6.38 Q4 '23: -5.56 Q1 '24: -3.20 Q2 '24: -2.79 Q3 '24: -2.29 Q4 '24: -1.34 Q1 '25: 2.64 Q2 '25: 2.27 Q3 '25: 1.78 Q4 '25: 2.58 Q1 '26: -0.41 Q2 '26: -1.35 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.